Established Uses
Blood-forming stem-cell transplantation is used for selected blood, immune, and inherited disorders. The treatment setting and regulatory pathway depend on the product and procedure.
Regenerative Medicine in Pasadena
Stem Cells
Understand established care, emerging research, and your regenerative-medicine options.
Book Your AppointmentWhat Are Stem Cells?
Stem cells can self-renew and develop into specialized cell types. Their capabilities depend on the cell type and environment; not every stem cell can form every tissue.
Product and purpose matter: Some cellular therapies have established medical uses. That does not establish the safety or benefit of products marketed for general rejuvenation, joint repair, or wellness.
Established Care and Emerging Research
Stem-cell medicine includes both well-established clinical care and experimental approaches. Approval applies to a specific product and indication.
A Specific MSC Approval
FDA approved Ryoncil, a donor bone-marrow-derived mesenchymal stromal cell therapy, for steroid-refractory acute graft-versus-host disease in patients aged two months and older. It is not an approval for routine joint or anti-aging treatments.
Research Applications
Scientists study differentiation, signaling, immune effects, and tissue responses. The strength of evidence varies by cell type, preparation, route, and condition.
Claims to Examine
Promises of cartilage regrowth, reversing aging, or treating many unrelated illnesses need product-specific human evidence. A general stem-cell label is not enough.
Stem-Cell Research: Repair and Cell Signaling
Researchers are exploring how stem cells and their signals interact with the body’s repair processes. Much of this work focuses on mesenchymal stromal cells (MSCs), with findings from laboratory and animal research that do not by themselves establish benefits in patients.
Immune and Inflammatory Signaling
Laboratory and animal studies show that MSCs can interact with immune cells and influence inflammatory signals. Scientists are studying when these effects may be helpful; they do not establish a universal immune boost or an anti-inflammatory benefit for every patient.
Tissue-Repair Mechanisms
Research examines how factors released by MSCs affect nearby cells and the environment around injured tissue. These signaling effects may be more important than the transplanted cells permanently replacing damaged tissue.
Blood-Vessel and Cell-Survival Signals
Preclinical studies explore effects on new blood-vessel formation and cell survival under stress. These are potential mechanisms of repair, not proof that a commercial treatment restores circulation or regenerates an organ.
Cell-to-Cell Communication
The secretome—the collection of substances released by cells—and extracellular vesicles are active research areas. Their contents and effects depend on the cell source and manufacturing process; they are different from living stem cells.
How to interpret these studies: Biological mechanisms and promising laboratory findings are not the same as proven clinical benefits. Results cannot be generalized across cell sources, products, delivery routes, or patients, and do not establish anti-aging or whole-body rejuvenation effects. See the research reviews in Selected References below.
Understanding the Sources
Different tissues yield different cells and biological materials. A tissue product is not automatically a viable stem-cell product.
Bone Marrow and Adipose Tissue
These patient-derived sources are discussed in regenerative medicine. Processing and intended use affect both biological properties and regulatory requirements.
Cord Blood
Contains blood-forming cells used in particular transplant products and clinical settings. Cord blood differs from cord tissue.
Cord Tissue and Wharton’s Jelly
Wharton’s jelly is connective tissue within the umbilical cord. Its presence in a product does not establish viable MSC content or a clinical benefit.
Placental Membranes and Amniotic Fluid
Placental membranes are tissues, not fluid. Amniotic fluid is a separate material. Composition, processing, and appropriate use must be considered individually.
Autologous and Allogeneic: What Do They Mean?
These terms describe whose cells or tissue are involved.
Autologous
Material comes from the same person receiving it. This does not eliminate contamination, processing, or procedure-related risks.
Allogeneic
Material comes from another person. Donor screening, consent, traceability, and immune compatibility are relevant. Not all donated products have their cells or DNA removed.
IV, Joint, and Exosome-Combination Questions
Delivery route and the exact product shape the evidence and risks.
IV Administration
Some approved cellular therapies use IV delivery for specific conditions. That does not validate general stem-cell wellness infusions. Infusion reactions, infection, and product-specific risks require careful evaluation.
Joint Injections
Products marketed as stem-cell injections are not interchangeable with approved cellular medicines. Benefits for arthritis or cartilage repair cannot be assumed; joint procedures also carry infection and bleeding risks.
Combining With Exosomes
Exosomes are vesicles, not living cells. Combining them with cells does not establish added benefit or safety. There are no FDA-approved exosome products.
A Product-Specific Discussion
Ask what is being administered, what human evidence supports that route and condition, and what regulatory authorization applies. This page does not indicate that these procedures are offered.
Inhaled Stem Cells: What Is Being Studied?
Inhaled delivery is being explored as a way to bring investigational materials directly to the respiratory tract. The phrase “inhaled stem cells” can describe very different products, so the exact contents matter.
Living Cells Versus Cell-Derived Products
Researchers have investigated aerosol delivery of cells and of cell-derived materials. Many inhalation studies involve secretome or extracellular vesicles, including exosomes, rather than living stem cells. Evidence for one cannot be used to validate the others.
Why Researchers Are Interested
Local delivery may help researchers target the lung surface. A 2020 Nature Communications study reported repair-related effects from inhaled lung-cell secretome and exosomes in animal models. It did not establish benefits in people or test a general wellness treatment.
Questions Still Being Studied
Researchers must determine how nebulization affects cell viability or product integrity, where the material deposits, and whether delivery is consistent. Appropriate dosing, effectiveness, and longer-term safety require product-specific human studies.
Safety and Clinical Context
Inhalation does not make a product automatically safe. Sterility, airway tolerability, and the effects of the device on the material need evaluation. A product studied by injection cannot be assumed suitable for nebulization.
Research context: The studies cited here do not establish inhaled stem-cell or exosome treatment as routine care. Any proposed use requires product-specific evidence and applicable regulatory authorization. This discussion is educational and does not indicate that Alpha Hormones offers inhaled cellular products.
Safety, Sourcing, and Regulatory Standards
Good information identifies the exact product and the evidence behind it.
Potential Risks
Unapproved regenerative products have been associated with serious infections, unwanted immune responses, and abnormal tissue growth. Risks vary with the cells, processing, and route.
Manufacturing and Screening
Donor screening, consent, sterility testing, identity, and traceability matter. Facility registration or cGMP claims do not equal FDA product approval.
U.S. Oversight
Regulation depends on factors including manipulation, intended use, and product characteristics. “Minimally manipulated” alone does not establish an exemption; state laws do not replace federal requirements.
Clinical Research
For an investigational product, ask about FDA authorization where required, ethics review, consent, and monitoring. A trial registry listing alone does not establish authorization.
Understanding State Stem-Cell Laws
State policies are evolving. Understanding their scope can help you ask better questions about a proposed treatment.
Florida: A Defined State Framework
Florida law permits certain stem-cell therapies without FDA approval in orthopedics, wound care, and pain management, subject to physician scope of practice and specific sourcing, facility, cell-viability, consent, and advertising requirements.
Texas: Eligibility-Based Access
Texas has a separate investigational stem-cell framework for qualifying patients with severe chronic disease or terminal illness. Eligibility includes physician evaluation of approved alternatives and a written recommendation for a specific class of treatment; additional safeguards apply.
State permission and FDA approval are different. These frameworks do not establish safety or effectiveness, grant FDA approval, or replace applicable federal requirements. They do not authorize treatment in California. This overview is educational and is not an offer or referral for investigational treatment in another state.
International Research: Questions Worth Asking
Regulatory standards differ across countries. Location alone does not establish safety or quality.
Review the Program, Not Just the Destination
- Which national authority oversees the exact product and study?
- Is there independent ethics review and transparent human evidence?
- Who manages complications and follow-up after returning home?
- Are costs, consent, and alternatives explained clearly?
Alpha Hormones provides education about these considerations. This page does not coordinate or endorse an overseas treatment program.
Your Consultation at Alpha Hormones®
Our Pasadena team helps you evaluate regenerative-medicine claims in the context of your own health.
Review Your History
Bring relevant imaging, previous treatments, medication lists, and a clear description of your goals.
Understand Your Options
Discuss the evidence, established alternatives, and whether further specialist evaluation is appropriate. The consultation is for medical evaluation and discussion of evidence and established alternatives; it is not a booking for a stem-cell procedure.
Frequently Asked Questions
Clear answers about regenerative medicine and your consultation.
Are all stem-cell treatments experimental?
No. Some cellular therapies and transplant approaches have established uses. Other marketed applications remain unapproved; the exact product and indication matter.
Does FDA approval of one MSC product apply to others?
No. Approval of Ryoncil for a specific condition does not validate other preparations or uses for joints, longevity, or general wellness.
Are my own cells automatically safe or exempt from regulation?
No. Processing, intended use, and procedure-related risks still matter.
Does a cord-tissue product contain live stem cells?
Not necessarily. Product-specific evidence is needed to establish cell identity and viability.
Can stem cells and exosomes be combined?
Combining them does not establish clinical benefit or safety. The exact combination needs evidence and applicable authorization.
Does cGMP mean FDA-approved?
No. Manufacturing standards and approval are different requirements.
Is international treatment safer or more advanced?
Location does not establish quality. Review the exact program, authorization, evidence, and complication plan.
Will insurance cover treatment?
Coverage depends on the diagnosis, product, service, and plan. Confirm benefits; do not assume investigational procedures are covered.
What happens at a consultation?
Your provider reviews your history and goals, discusses the evidence, and helps identify appropriate next steps.
Can stem cells be inhaled?
Aerosol delivery is an area of research. Many studies use cell-derived secretome or vesicles rather than living cells. Findings remain product-specific and do not establish inhaled products as routine care or show that an injectable preparation can be nebulized.
Make an Informed Next Step
Book a medical consultation to discuss your health goals, research questions, and care options.
Book Your AppointmentImportant Information
This page is educational and does not replace medical advice. Regulatory status and evidence are product- and indication-specific. Consultation does not establish treatment availability or guarantee outcomes.
Selected References
Read product-specific information alongside general regulatory guidance. Older summaries may not reflect newer approvals.
